These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16928222

  • 21. Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection.
    Bang CS, Lim H, Jeong HM, Shin WG, Choi JH, Soh JS, Kang HS, Yang YJ, Hong JT, Shin SP, Suk KT, Lee JJ, Baik GH, Kim DJ.
    Gut Microbes; 2020 Sep 02; 11(5):1314-1323. PubMed ID: 32362221
    [Abstract] [Full Text] [Related]

  • 22. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
    Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.
    World J Gastroenterol; 2015 Jul 14; 21(26):8132-9. PubMed ID: 26185386
    [Abstract] [Full Text] [Related]

  • 23. Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial.
    Lee JY, Kim N, Park KS, Kim HJ, Park SM, Baik GH, Shim KN, Oh JH, Choi SC, Kim SE, Kim WH, Park SY, Kim GH, Lee BE, Jo Y, Hong SJ.
    BMC Gastroenterol; 2016 Jul 26; 16(1):79. PubMed ID: 27460100
    [Abstract] [Full Text] [Related]

  • 24. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM, Huang J, Xia HH, Fung FM, Tong TS, Cheung KL, Ho VY, Lai KC, Chan CK, Chan AO, Hui CK, Lam SK, Wong BC.
    J Gastroenterol Hepatol; 2005 Jun 26; 20(6):935-40. PubMed ID: 15946144
    [Abstract] [Full Text] [Related]

  • 25. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
    de Boer SY, v d Meeberg PC, Siem H, de Boer WA.
    Neth J Med; 2003 Jun 26; 61(6):218-22. PubMed ID: 12956102
    [Abstract] [Full Text] [Related]

  • 26. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP, Fuentes J, Carpio D, Tito L, Guardiola J, Tomas A, Olivares D, Calvet X.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1249-53. PubMed ID: 15882246
    [Abstract] [Full Text] [Related]

  • 27. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L, Estrada R, Trujillo M, Emami S.
    Am J Gastroenterol; 1997 Dec 15; 92(12):2213-5. PubMed ID: 9399755
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec 15; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 29. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G, Schwery S, Giezendanner S, Flury R, Wüst J, Meyenberger C, Wirth HP.
    Schweiz Med Wochenschr; 1996 Feb 03; 126(5):153-8. PubMed ID: 8685685
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
    Thong-Ngam D, Mahachai V.
    J Med Assoc Thai; 2006 Sep 03; 89 Suppl 3():S119-25. PubMed ID: 17718277
    [Abstract] [Full Text] [Related]

  • 33. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN, Sung JJ, Yuen NW, Ng PW, Wong KC, Chung EC, Lim BH, Choi CH, Li TH, Ma HC, Kwok SP.
    Am J Gastroenterol; 1997 Mar 03; 92(3):438-41. PubMed ID: 9068464
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
    Wang Z, Wu S.
    Singapore Med J; 2012 Apr 03; 53(4):273-6. PubMed ID: 22511052
    [Abstract] [Full Text] [Related]

  • 36. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
    Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS, Wu DC, Hu TH.
    Helicobacter; 2012 Jun 03; 17(3):216-23. PubMed ID: 22515360
    [Abstract] [Full Text] [Related]

  • 37. [Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
    Gisbert JP, Boixeda D, de Rafael L, Redondo C, Martín de Argila C, Bermejo F.
    Rev Esp Enferm Dig; 1996 May 03; 88(5):317-22. PubMed ID: 8764537
    [Abstract] [Full Text] [Related]

  • 38. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
    Wong WM, Gu Q, Chu KM, Yee YK, Fung FM, Tong TS, Chan AO, Lai KC, Chan CK, Wong BC.
    Aliment Pharmacol Ther; 2006 Feb 01; 23(3):421-7. PubMed ID: 16423001
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.
    Helicobacter; 2008 Dec 01; 13(6):542-9. PubMed ID: 19166420
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.